14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $60.86 $75.66 Friday, 3rd May 2024 CYTK stock ended at $65.27. This is 1.45% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.47% from a day low at $65.00 to a day high of $66.61.
90 days $60.86 $81.33
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
Mar 01, 2021 $19.24 $20.09 $18.77 $19.66 1 077 599
Feb 26, 2021 $19.51 $20.36 $18.34 $18.73 4 025 213
Feb 25, 2021 $20.60 $21.46 $19.64 $19.85 515 192
Feb 24, 2021 $20.14 $20.79 $20.09 $20.75 524 631
Feb 23, 2021 $20.48 $21.11 $20.07 $20.26 780 248
Feb 22, 2021 $21.05 $21.48 $20.55 $20.63 521 981
Feb 19, 2021 $21.18 $22.48 $21.17 $21.28 1 183 947
Feb 18, 2021 $22.82 $22.82 $20.99 $21.01 1 116 433
Feb 17, 2021 $20.90 $22.24 $20.42 $21.86 475 858
Feb 16, 2021 $22.00 $22.12 $20.57 $20.90 977 575
Feb 12, 2021 $23.07 $23.07 $21.97 $22.13 422 537
Feb 11, 2021 $23.44 $23.93 $22.41 $22.76 427 829
Feb 10, 2021 $23.75 $24.20 $22.67 $23.16 454 567
Feb 09, 2021 $23.80 $24.10 $23.34 $23.65 479 412
Feb 08, 2021 $23.27 $24.27 $23.11 $23.75 589 577
Feb 05, 2021 $23.15 $23.53 $22.97 $23.07 521 816
Feb 04, 2021 $22.97 $23.11 $22.21 $22.89 376 119
Feb 03, 2021 $22.40 $23.80 $22.20 $22.75 1 095 275
Feb 02, 2021 $20.27 $22.11 $19.85 $22.01 725 208
Feb 01, 2021 $19.74 $20.30 $19.24 $20.19 1 115 769
Jan 29, 2021 $20.00 $20.60 $19.00 $19.67 936 182
Jan 28, 2021 $20.40 $20.60 $19.65 $20.00 1 243 611
Jan 27, 2021 $20.10 $20.57 $19.35 $20.25 898 197
Jan 26, 2021 $20.99 $21.36 $20.10 $20.29 569 724
Jan 25, 2021 $20.27 $20.87 $19.92 $20.84 406 580
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT